WallStreetZenWallStreetZen

NYSE: ABT
Abbott Laboratories Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ABT

Based on 6 analysts offering 12 month price targets for Abbott Laboratories.
Min Forecast
$121.00+13.23%
Avg Forecast
$127.67+19.47%
Max Forecast
$140.00+31.01%

Should I buy or sell ABT stock?

Based on 6 analysts offering ratings for Abbott Laboratories.
Strong Buy
Strong Buy
3 analysts 50%
Buy
3 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ABT stock forecasts and price targets.

ABT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-22
lockedlocked$00.00+00.00%2024-04-18
lockedlocked$00.00+00.00%2024-04-04
lockedlocked$00.00+00.00%2024-04-03
lockedlocked$00.00+00.00%2024-01-25
Wells Fargo
Bottom 10%
10
Strong BuyMaintains$121.00+13.23%2023-12-13

1 of 1

Forecast return on equity

Is ABT forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.16%

Forecast return on assets

Is ABT forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

ABT revenue forecast

What is ABT's revenue in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
$41.7B+3.86%
Avg 2 year Forecast
$44.5B+11.02%
Avg 3 year Forecast
$47.4B+18.29%
ABT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ABT earnings growth forecast

How is ABT forecast to perform vs Medical Devices companies and vs the US market?
Company
23.18%
Industry
24.7%
Market
21.46%
ABT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
ABT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
ABT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

ABT revenue growth forecast

How is ABT forecast to perform vs Medical Devices companies and vs the US market?
Company
5.75%
Industry
8.18%
Market
9.92%
ABT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ABT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ABT vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
ABT$106.86$127.67+19.47%Strong Buy
SYK$337.15$359.60+6.66%Buy
BSX$73.26$77.11+5.26%Strong Buy
MDT$79.25$94.00+18.61%Buy
DXCM$138.01$149.71+8.48%Strong Buy
View Top Medical Device Stocks

Abbott Laboratories Stock Forecast FAQ

Is Abbott Laboratories Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NYSE: ABT) stock is to Strong Buy ABT stock.

Out of 6 analysts, 3 (50%) are recommending ABT as a Strong Buy, 3 (50%) are recommending ABT as a Buy, 0 (0%) are recommending ABT as a Hold, 0 (0%) are recommending ABT as a Sell, and 0 (0%) are recommending ABT as a Strong Sell.

If you're new to stock investing, here's how to buy Abbott Laboratories stock.

What is ABT's revenue growth forecast for 2024-2026?

(NYSE: ABT) Abbott Laboratories's forecast annual revenue growth rate of 5.75% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.18%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.92%.

Abbott Laboratories's revenue in 2024 is $40,109,000,000.On average, 6 Wall Street analysts forecast ABT's revenue for 2024 to be $72,280,241,574,373, with the lowest ABT revenue forecast at $72,177,072,722,102, and the highest ABT revenue forecast at $72,432,672,308,609. On average, 6 Wall Street analysts forecast ABT's revenue for 2025 to be $77,263,720,350,514, with the lowest ABT revenue forecast at $76,927,122,361,396, and the highest ABT revenue forecast at $77,573,842,897,750.

In 2026, ABT is forecast to generate $82,325,362,238,137 in revenue, with the lowest revenue forecast at $81,667,437,616,830 and the highest revenue forecast at $82,898,429,406,975.

What is ABT's forecast return on assets (ROA) for 2024-2027?

(NYSE: ABT) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of N/A.

What is ABT's Price Target?

According to 6 Wall Street analysts that have issued a 1 year ABT price target, the average ABT price target is $127.67, with the highest ABT stock price forecast at $140.00 and the lowest ABT stock price forecast at $121.00.

On average, Wall Street analysts predict that Abbott Laboratories's share price could reach $127.67 by Apr 22, 2025. The average Abbott Laboratories stock price prediction forecasts a potential upside of 19.47% from the current ABT share price of $106.86.

What is ABT's forecast return on equity (ROE) for 2024-2027?

(NYSE: ABT) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.